South Africa Launches Breakthrough HIV Prevention Injection Lenacapavir
South Africa launches Lenacapavir, a twice-yearly injectable HIV prevention drug, marking a major scientific breakthrough in the fight against the world’s largest epidemic.
HIV Prevention
Zimbabwe Launches Twice-Yearly HIV Prevention Injection, Targets Epidemic
Zimbabwe introduces biannual HIV prevention injections, aiming to reduce new infections through improved adherence and accessibility in high-risk communities.
Lenacapavir: Injectable HIV Drug Named Science’s Breakthrough of the Year
Lenacapavir, an injectable HIV drug providing six months of protection per shot, has been named Breakthrough of the Year by “Science”, marking a significant advancement in HIV prevention.